Jeri S. Roth

597 total citations
18 papers, 514 citations indexed

About

Jeri S. Roth is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Jeri S. Roth has authored 18 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Molecular Biology and 6 papers in Virology. Recurrent topics in Jeri S. Roth's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). Jeri S. Roth is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). Jeri S. Roth collaborates with scholars based in United States, Italy and Malaysia. Jeri S. Roth's co-authors include James A. Kelley, John S. Driscoll, Víctor E. Márquez, Hiroaki Mitsuya, Samuel Broder, Christopher K. H. Tseng, Harry Ford, Shizuko Aoki, David G. Johns and Jerry M. Collins and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

Jeri S. Roth

18 papers receiving 481 citations

Peers

Jeri S. Roth

VIROL

EPIDE

Roman Sterzycki United States

Georges Maury France

Marianne E. Federici United States

Paul R. Brodfuehrer United States

Ed W. McLean United States

Tominaga Fukazawa Japan

Woo‐Baeg Choi United States

Katherine Z. Borysko United States

Mu‐Ill Lim United States

Christophe Mathé France

Roman Sterzycki United States

Jeri S. Roth

244 ×1.0

271 ×1.1

169 ×1.1

VIROL

93 ×0.7

EPIDE

261 ×2.4

Citations per year, relative to Jeri S. Roth Jeri S. Roth (= 1×) peers Roman Sterzycki

Countries citing papers authored by Jeri S. Roth

Since Specialization

Citations

This map shows the geographic impact of Jeri S. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeri S. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeri S. Roth more than expected).

Fields of papers citing papers by Jeri S. Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeri S. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeri S. Roth. The network helps show where Jeri S. Roth may publish in the future.

Co-authorship network of co-authors of Jeri S. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Jeri S. Roth. A scholar is included among the top collaborators of Jeri S. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeri S. Roth. Jeri S. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Roth, Jeri S., et al.. (2000). Determination of lodenosine and its major metabolite in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry. 35(11). 1313–1319. 2 indexed citations

Roth, Jeri S., Cynthia McCully, Frank M. Balis, David G. Poplack, & James A. Kelley. (1999). 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition1. Drug Metabolism and Disposition. 27(10). 1128–1132. 2 indexed citations

Roth, Jeri S., Cynthia McCully, Frank M. Balis, David G. Poplack, & James A. Kelley. (1999). 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.. PubMed. 27(10). 1128–32. 6 indexed citations

Roth, Jeri S., Harry Ford, Masatoshi Tanaka, Hiroaki Mitsuya, & James A. Kelley. (1998). Determination of 2′-β-fluoro-2′,3′-dideoxyadenosine, an experimental anti-AIDS drug, in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 712(1-2). 199–210. 13 indexed citations

Driscoll, John S., M. Arshad Siddiqui, Harry Ford, et al.. (1996). Lipophilic, Acid-Stable, Adenosine Deaminase-Activated Anti-HIV Prodrugs for Central Nervous System Delivery. 3. 6-Amino Prodrugs of 2‘-β-Fluoro-2‘,3‘-dideoxyinosine. Journal of Medicinal Chemistry. 39(8). 1619–1625. 15 indexed citations

Siddiqui, M. Arshad, John S. Driscoll, Víctor E. Márquez, et al.. (1992). Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines. Journal of Medicinal Chemistry. 35(12). 2195–2201. 20 indexed citations

Ward, Frank T., James A. Kelley, Jeri S. Roth, et al.. (1991). Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.. PubMed. 51(7). 1803–10. 11 indexed citations

Márquez, Víctor E., Christopher K. H. Tseng, Hiroaki Mitsuya, et al.. (1990). Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. Journal of Medicinal Chemistry. 33(3). 978–985. 183 indexed citations

Heideman, Richard L., et al.. (1989). Reverse Phase HPLC Determination and Murine Pharmacokinetics of Arabinosyl-5-azacytosine. Journal of Liquid Chromatography. 12(9). 1613–1633. 3 indexed citations

10.

Collins, Jerry M., R W Klecker, James A. Kelley, et al.. (1988). Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid.. Journal of Pharmacology and Experimental Therapeutics. 245(2). 466–470. 53 indexed citations

11.

Heideman, Richard L., James A. Kelley, Roger J. Packer, et al.. (1988). A pediatric phase I and pharmacokinetic study of spirohydantoin mustard.. PubMed. 48(8). 2292–5. 7 indexed citations

12.

Márquez, Víctor E., Christopher K. H. Tseng, James A. Kelley, et al.. (1987). 2',3'-Dideoxy-2'-fluoro-ara-a. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). Biochemical Pharmacology. 36(17). 2719–2722. 96 indexed citations

13.

Driscoll, John S., et al.. (1986). Spiromustine Analogues. Relationships between Structure, Plasma Stability, and Antitumor Activity. Journal of Pharmaceutical Sciences. 75(3). 313–316. 3 indexed citations

14.

Kelley, James A., John S. Driscoll, John J. McCormack, Jeri S. Roth, & Víctor E. Márquez. (1986). Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides. Journal of Medicinal Chemistry. 29(11). 2351–2358. 25 indexed citations

15.

Litterst, Charles L., Jeri S. Roth, & James A. Kelley. (1985). Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats. Investigational New Drugs. 3(3). 263–272. 7 indexed citations

16.

Curt, Gregory A., James A. Kelley, Robert L. Fine, et al.. (1985). A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880).. PubMed. 45(7). 3359–63. 25 indexed citations

17.

Rapaka, Rao S., Jeri S. Roth, C.T. Viswanathan, et al.. (1982). Improved method for the analysis of furosemide in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 227(2). 463–469. 25 indexed citations

18.

Rapaka, Rao S., Jeri S. Roth, & Vadlamani K. Prasad. (1982). Facile hydrolytic cleavage of N,O-diheptafluorobutyryl derivatives of thyroidal amino acids. Journal of Chromatography A. 236(2). 493–495. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact